Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
CD16 ANTIBODY AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2023/274183
Kind Code:
A1
Abstract:
The present invention relates to a CD16 antibody and the use thereof. Specifically, disclosed are an antibody or an antigen-binding fragment specifically binding CD16, and an encoding nucleic acid, an expression vector and an expression cell thereof, a preparation method therefor, a pharmaceutical composition thereof, and the use thereof for treating diseases, such as the use thereof in the treatment of tumors. The CD16 antibody holds great significance for the development of a CD16 antibody therapeutic drug and a detection reagent.

Inventors:
WANG QIONG (CN)
FU YAYUAN (CN)
YANG CUIQING (CN)
CAO ZHUOXIAO (CN)
TANG RENHONG (CN)
REN JINSHENG (CN)
Application Number:
PCT/CN2022/101713
Publication Date:
January 05, 2023
Filing Date:
June 28, 2022
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
JIANGSU SIMCERE PHARM CO LTD (CN)
International Classes:
C07K16/28; A61K39/395; A61P35/00; C07K16/46; C12N1/21; C12N5/10; C12N15/13; C12N15/85; C12R1/19
Domestic Patent References:
WO2019028027A12019-02-07
WO2018217947A12018-11-29
WO1994004678A11994-03-03
WO1995004079A11995-02-09
WO1996034103A11996-10-31
WO1994025591A11994-11-10
WO1999037681A21999-07-29
WO2000040968A12000-07-13
WO2000043507A12000-07-27
WO2000065057A12000-11-02
WO2001040310A22001-06-07
WO2001044301A12001-06-21
WO2002048193A22002-06-20
WO1997049805A21997-12-31
WO2001021817A12001-03-29
WO2003035694A22003-05-01
WO2003054016A22003-07-03
WO2003055527A22003-07-10
WO2003050531A22003-06-19
WO2001090190A22001-11-29
WO2003025020A12003-03-27
WO2004041867A22004-05-21
WO2004041862A22004-05-21
WO2004041865A22004-05-21
WO2004041863A22004-05-21
WO2004062551A22004-07-29
WO2005044858A12005-05-19
WO2006040153A22006-04-20
WO2006079372A12006-08-03
WO2006122786A22006-11-23
WO2006122787A12006-11-23
WO2006122825A22006-11-23
WO2016177846A12016-11-10
Foreign References:
CN108101988A2018-06-01
CN202110732732A2021-06-29
EP1134231A12001-09-19
US5807715A1998-09-15
US5821333A1998-10-13
US20100286374A12010-11-11
CN201110459100A2011-12-31
EP2101823B12016-11-23
Other References:
GHISLAINE BEHAR, SOPHIE SIBÉRIL, AGNÈS GROULET, PATRICK CHAMES, MARTINE PUGNIÈRE, CHARLOTTE BOIX, CATHERINE SAUTÈS-FRIDMAN, JEAN-L: "Isolation and characterization of anti-Fc[gamma]RIII (CD16) llama single-domain antibodies that activate natural killer cells", PROTEIN ENGINEERING, DESIGN AND SELECTION JANUARY 2008 OXFORD UNIVERSITY PRESS GB, vol. 21, no. 1, 1 January 2008 (2008-01-01), pages 1 - 10, XP002646408, DOI: 10.1093/PROTEIN/GZM064
GONZáLEZ CRISTINA; CHAMES PATRICK; KERFELEC BRIGITTE; BATY DANIEL; ROBERT PHILIPPE; LIMOZIN LAURENT: "Nanobody-CD16 Catch Bond Reveals NK Cell Mechanosensitivity", BIOPHYSICAL JOURNAL, ELSEVIER, AMSTERDAM, NL, vol. 116, no. 8, 1 January 1900 (1900-01-01), AMSTERDAM, NL, pages 1516 - 1526, XP085670553, ISSN: 0006-3495, DOI: 10.1016/j.bpj.2019.03.012
VAN FAASSEN HENK, JO DONG-HYEON, RYAN SHANNON, LOWDEN MICHAEL J., RAPHAEL SHALINI, MACKENZIE C. ROGER, LEE SEUNG-HWAN, HUSSACK GRE: "Incorporation of a Novel CD16-Specific Single-Domain Antibody into Multispecific Natural Killer Cell Engagers With Potent ADCC", MOLECULAR PHARMACEUTICS, AMERICAN CHEMICAL SOCIETY, US, vol. 18, no. 6, 7 June 2021 (2021-06-07), US , pages 2375 - 2384, XP093018471, ISSN: 1543-8384, DOI: 10.1021/acs.molpharmaceut.1c00208
KORNDORFER, I. P.BESTE, G.SKERRA, A., PROTEINS, vol. 53, 2003, pages 121 - 129
ROQUE, A. C. A.LOWE, C. R.TAIPA, M. A.: "Antibodies and genetically engineered related molecules: production and purification", BIOTECHNOL. PROG., vol. 20, 2004, pages 639 - 654
HAMERS-CASTERMAN ET AL., NATURE, vol. 363, 1993, pages 446 - 8
MUYLDERMANS, J BIOTECHNOL., vol. 74, no. 4, June 2001 (2001-06-01), pages 277 - 302
MORRISON: "Transfectomas Provide Novel Chimeric Antibodies", SCIENCE, vol. 229, no. 4719, 1985, pages 1202 - 1207, XP001030113, DOI: 10.1126/science.3929380
GILLIES ET AL., J IMMUNOL METHODS, vol. 125, no. 1-2, 20 December 1989 (1989-12-20), pages 191 - 202
KABAT, E. A., WU, T. T., BILOFSKY, H.: "Unusual distributions of amino acids in complementarity determining (hypervariable) segments of heavy and light chains of immunoglobulins and their possible roles in specificity of antibody-combining sites", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 252, no. 19, 1977, pages 6609 - 6616
KABAT ET AL.: "Sequences of Proteins of Immunological Interest", 1991, UNITED STATES DEPARTMENT OF HEALTH AND HUMAN SERVICES
CHOTHIA, C.LESK, A. M.: "Canonical structures for the hypervariable regions of immunoglobulins", JOURNAL OF MOLECULAR BIOLOGY, vol. 196, no. 4, 1987, pages 901 - 917, XP024010426, DOI: 10.1016/0022-2836(87)90412-8
AL-LAZIKANI, B.LESK, A. M.CHOTHIA, C.: "Standard conformations for the canonical structures of immunoglobulins", JOURNAL OF MOLECULAR BIOLOGY, vol. 273, no. 4, 1997, pages 927 - 948, XP004461383, DOI: 10.1006/jmbi.1997.1354
MACCALLUM, R. M.MARTIN, A. C.THORNTON, J. M.: "Antibodyantigen interactions: contact analysis and binding site topography", JOURNAL OF MOLECULAR BIOLOGY, vol. 262, no. 5, 1996, pages 732 - 745, XP002242391, DOI: 10.1006/jmbi.1996.0548
ABHINANDAN, K. R.MARTIN, A. C.: "Analysis and improvements to Kabat and structurally correct numbering of antibody variable domains", MOLECULAR IMMUNOLOGY, vol. 45, no. 14, 2008, pages 3832 - 3839, XP023437109, DOI: 10.1016/j.molimm.2008.05.022
LEFRANC, M. P.POMMIE, C.RUIZ, M.GIUDICELLI, V.FOULQUIER, E.TRUONG, L.LEFRANC, G.: "IMGT unique numbering for immunoglobulin and T cell receptor variable domains and Ig superfamily V-like domains", DEVELOPMENTAL & COMPARATIVE IMMUNOLOGY, vol. 27, no. 1, 2003, pages 55 - 77, XP055585227, DOI: 10.1016/S0145-305X(02)00039-3
HONEGGER, A., PLUECKTHUN, A.: "Yet another numbering scheme for immunoglobulin variable domains: an automatic modelling and analysis tool", JOURNAL OF MOLECULAR BIOLOGY, vol. 309, no. 3, 2001, pages 657 - 670, XP004626893, DOI: 10.1006/jmbi.2001.4662
RIDGWAY, J. B.PRESTA, L. G.CARTER, P.: "Knobs-into-holes' engineering of antibody CH3 domains for heavy chain heterodimerization", PROTEIN ENGINEERING, DESIGN AND SELECTION, vol. 9, no. 7, 1996, pages 617 - 621, XP002610995, DOI: 10.1093/protein/9.7.617
DAVIS, J. H.APERLO, C.LI, Y.KUROSAWA, E.LAN, Y.LO, K. M.HUSTON, J. S.: "SEEDbodies: fusion proteins based on strand-exchange engineered domain (SEED) CH3 heterodimers in an Fc analogue platform for asymmetric binders or immunofusions and bispecific antibodies", PROTEIN ENGINEERING, DESIGN & SELECTION, vol. 23, no. 4, 2010, pages 195 - 202, XP055018770, DOI: 10.1093/protein/gzp094
GRAMER, M. J.VAN DEN BREMER, E. T.VAN KAMPEN, M. D.KUNDU, A.KOPFMANN, P.ETTER, E.PARREN, P. W.: "MAbs", vol. 3, November 2011, TAYLOR & FRANCIS, article "Production of stable bispecific IgG1 by controlled Fab-arm exchange: scalability from bench to large-scale manufacturing by application of standard approaches", pages: 546 - 557
ALTSCHUL, S. F.GISH, W.MILLER, W.MYERS, E. W.LIPMAN, D. J.: "Basic local alignment search tool", JOURNAL OF MOLECULAR BIOLOGY, vol. 215, no. 3, 1990, pages 403 - 410, XP002949123, DOI: 10.1006/jmbi.1990.9999
ALTSCHUL, S. F.MADDEN, T. L.SCHAFFER, A. A.ZHANG, J.ZHANG, Z.MILLER, W.LIPMAN, D. J.: "Gapped BLAST and PSI-BLAST: a new generation of protein database search programs", NUCLEIC ACIDS RESEARCH, vol. 25, no. 17, 1997, pages 3389 - 3402, XP002905950, DOI: 10.1093/nar/25.17.3389
STADLER, C. R.BAHR-MAHMUD, H.CELIK, L.HEBICH, B.ROTH, A. S.ROTH, R. P.SAHIN, U.: "Elimination of large tumours in mice by mRNA-encoded bispecific antibodies", NATURE MEDICINE, vol. 23, no. 7, 2017, pages 815 - 817
"Remington's Pharmaceutical Sciences", 1990, MACKPRINTING COMPANY, pages: 1289 - 1329
SAMBROOK, J.FRITSCH, E. F.MANIATIS, T.: "Molecular Cloning: A Laboratory Manual, Second Edition", 1989, COLD SPRING HARBOR LABORATORY PRESS
FLEIT H.B. ET AL., PROC NATL ACAD SCI USA., May 1982 (1982-05-01)
Download PDF: